NEW YORK, July 21, 2017 /PRNewswire/ --
If you want a Stock Review on TDOC, HQY, MDSO, or PINC then come over to
On Thursday, shares in Purchase, New York headquartered Teladoc Inc. recorded a trading volume of 474,618 shares. The stock ended the session 2.27% lower at $34.45. The Company's shares have gained 5.51% in the last one month, 30.25% over the previous three months, and 108.79% on an YTD basis. The stock is trading 5.61% above its 50-day moving average and 49.27% above its 200-day moving average. Moreover, shares of Teladoc, which operates a telehealth platform that provides on-demand healthcare services to its members in the US, have a Relative Strength Index (RSI) of 52.34.
On July 17th, 2017, Teladoc announced the completion of its acquisition of Best Doctors, the world's leading expert medical consultation company focused on improving health outcomes for the most complex, critical, and costly medical issues. With its newly acquired global footprint, network of more than 50,000 medical experts, and unmatched reputation for delivering quality outcomes, the Company is prepared to deliver on its vision to provide a central, trusted source for patients to get resolution to their healthcare needs. The free research report on TDOC is available at:
Draper, Utah headquartered HealthEquity Inc.'s stock closed the day 1.37% lower at $47.64. A total volume of 835,872 shares was traded, which was above their three months average volume of 499,760 shares. The Company's shares have advanced 4.61% in the previous three months and 17.57% since the start of this year. The stock is trading 9.23% above its 200-day moving average. Additionally, shares of HealthEquity have an RSI of 43.01.
On July 05th, 2017, HealthEquity announced that it has entered into a partnership with First Interstate BancSystem, Inc., the parent company of First Interstate Bank and Bank of the Cascades, which will transition its health savings account (HSA) portfolio to the former. The ongoing partnership establishes HealthEquity as the HSA custodian for all current and future First Interstate HSA business. HealthEquity will also become custodian for all current HSA clients by September 28th, 2017. The complimentary report on HQY can be downloaded at:
Shares in New York headquartered Medidata Solutions Inc. recorded a trading volume of 1.22 million shares, which was higher than their three months average volume of 692,270 shares. The stock ended yesterday's trading session 0.95% lower at $75.78. The Company's shares have advanced 0.03% in the past month, 21.35% in the previous three months, and 52.57% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 0.56% and 26.62%, respectively. Furthermore, shares of Medidata Solutions, which provides cloud-based solutions for life sciences worldwide, have an RSI of 43.22.
On July 13th, 2017, Medidata Solutions announced the successful completion of the annual NEXT Conference series in Europe during June 2017, with events having occurred in Basel, Berlin, and London. Each event brought together leading industry experts to examine how data, insights, and technology are transforming the future of clinical trials and drug-development processes in a $4.0-billion, global, e-clinical technology industry. Visit us today and download our complete research report on MDSO for free at:
Charlotte, North Carolina headquartered Premier Inc.'s stock finished Thursday's session 0.48% higher at $35.54 with a total trading volume of 134,596 shares. The Company's shares have advanced 1.75% in the last one month, 7.18% over the previous three months, and 17.06% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 1.08% and 9.84%, respectively. Additionally, shares of Premier, which together with its subsidiaries, operates as a healthcare improvement company in the US, have an RSI of 51.14.
On July 19th, 2017, Premier announced that it is launching a national, opioid safety pilot with hospitals through its Hospital Improvement Innovation Network, which is part of the Centers for Medicaid & Medicare Services Partnership for Patients program. The effort is focused on measurably improving post-operative opioid pain management by providers, clinicians, and patients/families. The Safer Post-operative Pain Management: Reducing Opioid-related Harm pilot will officially launch in September 2017 and run through March 2018. Get free access to your technical report on PINC at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...
A prosthetic heart valve is an artificial device surgically implanted into the heart to replace a ...
PUVA or photochemotherapy is used to treat several skin disorders with the help of UV light and the ...View All